Sands Capital Ventures’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-22,544
Closed -$4.22M – 25
2022
Q3
$4.22M Hold
22,544
– – 1.23% 13
2022
Q2
$3.66M Hold
22,544
– – 1.01% 14
2022
Q1
$4.24M Hold
22,544
– – 0.89% 15
2021
Q4
$5.97M Hold
22,544
– – 0.89% 13
2021
Q3
$6.51M Buy
+22,544
New +$5.78M 0.98% 10

Other funds holding RGEN

Sands Capital Ventures's RGEN Position: Q4 2022 in Review

Sands Capital Ventures sold out of Repligen (RGEN) in Q4 2022, closing a stake of 22,544 shares — an estimated $4.22M sold.

Sands Capital Ventures first reported a position in RGEN in Q3 2021 and held it in 5 quarters. The position peaked at $6.51M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Sands Capital Ventures reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Sands Capital Ventures sold 22,544 Repligen shares in Q4 2022, an estimated $4.22M.
  • Sands Capital Ventures first reported a position in Repligen in Q3 2021 and held it in 5 quarters.
  • Sands Capital Ventures's Repligen position peaked at $6.51M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Sands Capital Ventures's 13F filing for Q4 2022, filed 13 Feb 2023.